Status:
COMPLETED
Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Lead Sponsor:
SOFAR S.p.A.
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether Mesalazine is effective in the treatment of the abdominal discomfort or pain of Irritable Bowel Syndrome patients.
Detailed Description
The present study is a prospective, double blind, randomised, multicenter trial designed to study the efficacy of mesalazine treatment on symptoms of IBS. In a subgroup of patients the efficacy of thi...
Eligibility Criteria
Inclusion
- IBS patients with positive diagnosis inclosing Rome III criteria
Exclusion
- Any organic or metabolic disease
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT00626288
Start Date
December 1 2007
End Date
July 1 2012
Last Update
July 26 2013
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedali Riuniti Torrette
Ancona, Ancona, Italy, 60100
2
Azienda Ospedaliero-Universitaria S.Orsola Malpighi
Bologna, Bologna, Italy, 40100
3
U.O. Medicina Interna- Osp. S.S.Annunziata
Cento, Ferrara, Italy, 44100
4
Azienda Sanitaria Unità Locale di Ferrara- Ospedale del Delta
Lagosanto, Ferrara, Italy, 44023